Romania's Competition Council investigates big pharma groups

02 June 2016

Romania’s Competition Council has initiated an investigation at Novartis Pharma Services Romania, the local subsidiary of the Swiss pharma group Novartis.

The investigation targets a possible abuse of dominant position by implementing a pilot project for direct distribution to certain pharmacies.

Novartis ranks second in Romania’s pharma sector, with sales of EUR 140 million in 2015 and a market share of 5.5%.

The Competition Council is also investigating British group GSK’s local subsidiary for a possible breach of the competition law.

The Competition Council published yesterday a report following a sectorial analysis of the pharma market.

editor@romania-insider.com

Normal

Romania's Competition Council investigates big pharma groups

02 June 2016

Romania’s Competition Council has initiated an investigation at Novartis Pharma Services Romania, the local subsidiary of the Swiss pharma group Novartis.

The investigation targets a possible abuse of dominant position by implementing a pilot project for direct distribution to certain pharmacies.

Novartis ranks second in Romania’s pharma sector, with sales of EUR 140 million in 2015 and a market share of 5.5%.

The Competition Council is also investigating British group GSK’s local subsidiary for a possible breach of the competition law.

The Competition Council published yesterday a report following a sectorial analysis of the pharma market.

editor@romania-insider.com

Normal
 

facebooktwitterlinkedin

1

Romania Insider Free Newsletters